These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 21077686)

  • 1. Organometallic anticancer compounds.
    Gasser G; Ott I; Metzler-Nolte N
    J Med Chem; 2011 Jan; 54(1):3-25. PubMed ID: 21077686
    [No Abstract]   [Full Text] [Related]  

  • 2. Metal-containing drugs and novel coordination complexes in therapeutic anticancer applications--part II.
    Kostova I
    Anticancer Agents Med Chem; 2010 Jun; 10(5):352-3. PubMed ID: 20545617
    [No Abstract]   [Full Text] [Related]  

  • 3. Editorial: Anticancer Ruthenium Complexes in Drug Discovery and Medicinal Chemistry.
    Thota S
    Mini Rev Med Chem; 2016; 16(10):771. PubMed ID: 27161007
    [No Abstract]   [Full Text] [Related]  

  • 4. Preface.
    Prudhomme M
    Anticancer Agents Med Chem; 2017; 17(1):3. PubMed ID: 28143384
    [No Abstract]   [Full Text] [Related]  

  • 5. Overview.
    Prudhomme M
    Anticancer Agents Med Chem; 2017; 17(1):2. PubMed ID: 28143383
    [No Abstract]   [Full Text] [Related]  

  • 6. Cyclometalated Ir(III) complexes as targeted theranostic anticancer therapeutics: combining HDAC inhibition with photodynamic therapy.
    Ye RR; Tan CP; He L; Chen MH; Ji LN; Mao ZW
    Chem Commun (Camb); 2014 Sep; 50(75):10945-8. PubMed ID: 25096019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-heterocyclic carbene metal complexes as bio-organometallic antimicrobial and anticancer drugs.
    Patil SA; Patil SA; Patil R; Keri RS; Budagumpi S; Balakrishna GR; Tacke M
    Future Med Chem; 2015; 7(10):1305-33. PubMed ID: 26144266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New applications of old metal-binding drugs in the treatment of human cancer.
    Schmitt SM; Frezza M; Dou QP
    Front Biosci (Schol Ed); 2012 Jan; 4(1):375-91. PubMed ID: 22202066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs.
    Liu W; Gust R
    Chem Soc Rev; 2013 Jan; 42(2):755-73. PubMed ID: 23147001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tracking antitumor metallodrugs: promising agents with the Ru(II)- and Fe(II)-cyclopentadienyl scaffolds.
    Morais TS; Valente A; Tomaz AI; Marques F; Garcia MH
    Future Med Chem; 2016 Apr; 8(5):527-44. PubMed ID: 27096164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Next Generation of Anticancer Metallopharmaceuticals: Cancer Stem Cell-Active Inorganics.
    Laws K; Suntharalingam K
    Chembiochem; 2018 Nov; 19(21):2246-2253. PubMed ID: 30109911
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent researches in metal supramolecular complexes as anticancer agents.
    Zhou CH; Zhang YY; Yan CY; Wan K; Gan LL; Shi Y
    Anticancer Agents Med Chem; 2010 Jun; 10(5):371-95. PubMed ID: 20380632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metal/N-heterocyclic carbene complexes: opportunities for the development of anticancer metallodrugs.
    Cisnetti F; Gautier A
    Angew Chem Int Ed Engl; 2013 Nov; 52(46):11976-8. PubMed ID: 24115500
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticancer metallodrugs: where is the next cisplatin?
    Hanif M; Hartinger CG
    Future Med Chem; 2018 Mar; 10(6):615-617. PubMed ID: 29411994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of Arene Ruthenium Antitumor Complexes.
    Su W; Tang Z; Li P
    Mini Rev Med Chem; 2016; 16(10):787-95. PubMed ID: 27161008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal Complexes in Cancer Treatment: Journey So Far.
    Kumar Singh A; Kumar A; Singh H; Sonawane P; Pathak P; Grishina M; Pal Yadav J; Verma A; Kumar P
    Chem Biodivers; 2023 Apr; 20(4):e202300061. PubMed ID: 36824028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platinum, palladium, gold and ruthenium complexes as anticancer agents: Current clinical uses, cytotoxicity studies and future perspectives.
    Lazarević T; Rilak A; Bugarčić ŽD
    Eur J Med Chem; 2017 Dec; 142():8-31. PubMed ID: 28442170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The progresses in curcuminoids-based metal complexes: especially in cancer therapy.
    Zhang Y; Khan AR; Fu M; Zhai Y; Yu A; Zhai G
    Future Med Chem; 2019 May; 11(9):1035-1056. PubMed ID: 31140861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using titanium complexes to defeat cancer: the view from the shoulders of titans.
    Cini M; Bradshaw TD; Woodward S
    Chem Soc Rev; 2017 Feb; 46(4):1040-1051. PubMed ID: 28124046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticancer Activity and Modes of Action of (arene) ruthenium(II) Complexes Coordinated to C-, N-, and O-ligands.
    Biersack B
    Mini Rev Med Chem; 2016; 16(10):804-14. PubMed ID: 27161009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.